Chemical Compound
Tobramycin; 4-O-(3-Amino-3-deoxy-a-d-glucopyranosyl)-2-deoxy-6-O-(2,6-diamino-2,3,6-trideoxy-a-d-ribo-hexopyranosyl)-l-streptamine; O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-D-Streptamine; 3'-Deoxykanamycin B; Deoxykanamycin B; NF 6; NSC 180514; Nebramycin 6; Nebramycin VI; Nebramycin factor 6; Tobracin; Tobradistin; Tobralex; Tobramax; Tobramaxin; Tobramicin; Tobramycetin; Tobramycin; Tobrex; Tobrin
CAS Registry Number
32986-56-4
Primary record
Tobramycin; 4-O-(3-Amino-3-deoxy-a-d-glucopyranosyl)-2-deoxy-6-O-(2,6-diamino-2,3,6-trideoxy-a-d-ribo-hexopyranosyl)-l-streptamine; O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-D-Streptamine; 3'-Deoxykanamycin B; Deoxykanamycin B; NF 6; NSC 180514; Nebramycin 6; Nebramycin VI; Nebramycin factor 6; Tobracin; Tobradistin; Tobralex; Tobramax; Tobramaxin; Tobramicin; Tobramycetin; Tobramycin; Tobrex; Tobrin
- 库存
- 6,018 克
- 纯度
- 99.5 %
- CAS
- 32986-56-4
化合物标识与属性
- CAS
- 32986-56-4
- PubChem CID
- 36294
- SMILES
- C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N
- Canonical SMILES
- NC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H](N)C[C@@H]2N)[C@H](N)C[C@@H]1O
名称与同义词
- tobramycin
- Nebramycin VI
- Tobramycetin
- Nebramycin 6
- Tobrex
- Tobi
- Tobramicin
- Aktob
- Deoxykanamycin B
- Tobramitsetin
- Nebramycin factor 6
- Tenebrimycin
- Tobradistin
- Tobramaxin
- Tenemycin
- Tobracin
- Tobralex
- vantobra
- Tobi Podhaler
- Tobramicina
- Tobramycine
- Obramycin
- Tobramycinum
- 32986-56-4
- 3'-Deoxykanamycin B
- Tobradex
- 1-Epitobramycin
- Bethkis
- Nebcin
- Tobramycin Base
- Distobram
- Gotabiotic
- Tobrasone
- Kitabis Pak
- Tobrased
- Nebicin
- Tobacin
- NEBRAMYCIN
- Brulamycin
- null
- torbamycin
- Burlamycin
- Bramitob
- Gernebcin
- Tobravisc
- Tocramax
- Tymbrineb
- Kitabis
- Obracin
- Nebris
- Sybryx
- Mixture Name
- Tobramycin CRS
- Tobracin (TN)
- Tobradex ST
- TOB[Tobramycin]
- Nebramycin factir 6
- TOBRAMYCIN SULFATE
- Tobrex (TN)
- Tobramycin Deuterated
- Nebcin (Sulfate)
- Tobramycin solution
- Lilly 47663
- Bethkis (TN)
- Tobramycin Inhalation
- VZ8RRZ51VK
- Tobramycine [INN-French]
- Tobramycinum [INN-Latin]
- AT02 - Tobramycin
- Tobramicina [INN-Spanish]
- Tobi (TN)
- UNII-VZ8RRZ51VK
- RefChem:6312
- NF 6
- Spectrum_001072
- SPRC-AB01
- TOBRAMYCIN [MI]
- C18H37N5O9
- 3 -Deoxykanamycin B
- AC1Q2AOW
- TOBRAMYCIN [INN]
- TOBRAMYCIN [JAN]
- Tobramycin for Inhalation
- Prestwick3_000544
- Spectrum2_000078
- Spectrum3_000588
- Spectrum4_000752
- Spectrum5_001038
- Tobramycin - high purity
- TOBRAMYCIN [HSDB]
- TOBRAMYCIN [USAN]
- ro-2H-pyran-3,5-diol
- DTXSID8023680
- TOBRAMYCIN [VANDF]
- Tobramycin (JP18/USP)
- HSDB 3259
- AC1L1VI0
- SCHEMBL2838
- TOBRAMYCIN [MART.]
- DTXCID903680
- NLVFBUXFDBBNBW-PBSUHMDJSA-N
- CHEMBL1747
- TOBRAMYCIN [USP-RS]
- TOBRAMYCIN [WHO-DD]
- BSPBio_000587
- BSPBio_002036
- KBioGR_001104
- KBioSS_001552
- CHEBI:28864
- MLS000069544
- BIDD:GT0503
- NSC 180514
- NSC-180514
- SPECTRUM1500579
- Tobramycin Inhalation Solution
- Tobramycin Ophthalmic Solution
- EINECS 251-322-5
- SPBio_000295
- tobramycin solution for inhalation
- MFCD00077885
- BPBio1_000647
- NF-6
- orb1309215
- Tobramycin [USAN:BAN:INN:JAN]
- Tobramycin Deuterated (>90%)
- TOBRAMYCIN [ORANGE BOOK]
- ERK5-2M21
- GTPL10930
- KBio2_001552
- KBio2_004120
- KBio2_006688
- KBio3_001536
- ZYLET COMPONENT TOBRAMYCIN
- AOB5629
- BRN 1357507
- J01GB01
- MSK7708
- S01AA12
- TOBRAMYCIN [EP MONOGRAPH]
- Tobramycin for identification CRS
- GLXC-06548
- HMS2090B16
- HMS2092M17
- HMS2096N09
- HMS3713N09
- Pharmakon1600-01500579
- TOBRAMYCIN [USP MONOGRAPH]
- Tobramycin Inhalation Solution Pak
- Tobramycin [USAN:INN:BAN:JAN]
- TOBRAMYCIN AND DEXAMETHASONE
- CID36294
- HY-B0441
- TOBRADEX COMPONENT TOBRAMYCIN
- Tobramycin [USAN:USP:INN:BAN:JAN]
- ZINC8214692
- Tox21_110626
- BBF-04568
- BDBM50366778
- CCG-39936
- EBC-27168
- HB4564
- MSK7708-100W
- Nebramycin Factor 6;Deoxykanamycin B
- NSC757352
- RW2731
- s2514
- TOBRASONE COMPONENT TOBRAMYCIN
- Tobradex (tobramycin + dexamethasone)
- AKOS016339662
- C18-H37-N5-O9
- MSK7708-1000W
- AN-9578
- AT16493
- CS-2547
- DB00684
- J4.533K
- KS-1405
- NSC-757352
- TOA-(1-6)TOB-(4-1)TOC
- TOBRADEX ST COMPONENT TOBRAMYCIN
- NCGC00016814-01
- NCGC00178852-01
- NCGC00178852-02
- TOA-(1-6)2TB-(4-1)TOC
- Tobramycin Solution in Water, 100ug/mL
- AT161114
- CPD000058793
- SAM001246911
- SC-45657
- SMR000058793
- SBI-0051915.P003
- Tobramycin Solution in Water, 1000ug/mL
- AB2000616
- CAS-32986-56-4
- LS-146940
- LS-187329
- Second International Standard for Tobramycin
- AB00513858
- B1856
- FT-0630567
- NS00003131
- T2503
- A-8891
- C00397
- D00063
- J10405
- (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
- AB00052438-12
- AB00052438_13
- AB00052438_14
- EN300-7480857
- 986T564
- A821546
- SR-01000721898
- SR-05000001726
- Tobramycin, Antibiotic for Culture Media Use Only
- Q-201837
- Q1758380
- SR-01000721898-2
- SR-05000001726-1
- SR-05000001726-2
- BRD-K05619559-001-10-1
- BRD-K05619559-001-12-7
- 4-(2,6-Diamino-2,3,6-trideoxy-alpha-D-glycopyranosyl)-6-(3-amino-3-deoxy-alpha-D-glycopyranosyl)-2-deoxystreptamine
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-
- O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine
- Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-tyrideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-
- (2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol
- (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol
- (2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol
- O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine
- Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-
- (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
- O(C1OC(CO)C(O)C(N)C1O)C2C(N)CC(N)C(OC3OC(CN)C(O)CC3N)C2O
- O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-6))-2-deoxy-L-streptamine
- TOY
- (1S,2S,3R,4S,6R)-4,6-diamino-3-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside
- (2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahyd
- (2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-3-((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl)oxy-2-hydroxycyclohexyl)oxy-6-(hydroxymethyl)oxane-3,5-diol
- >D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-
- 251-322-5
- 3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4))-2-deoxy-D-streptamine
- 4-AMINO-2-[4,6-DIAMINO-3-(3-AMINO-6-AMINOMETHYL-5-HYDROXY-TETRAHYDRO-PYRAN-2-YLOXY)-2-HYDROXY-CYCLOHEXYLOXY]-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL
- 4-O-(2,6-Diamino-2,3,6-trideoxy-alpha-D-glucopyranosyl)-6-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-2-deoxy-D-streptamine
- 6-O-(3-Amino-3-deoxy-alpha-D-glucopyranosyl)-4-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)-2-deoxy-D-streptamine
- 79645-27-5
- D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(2,6-DIAMINO-2,3,6-TRIDEOXY-.ALPHA.-D-RIBO-HEXOPYRANOSYL-(1->4))-2-DEOXY-
- D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-
- D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribohexopyranosyl-(1->4)]-2-deoxy-
- D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1.fwdarw.4)]-2-deoxy-
- D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-
- D-Streptamine, O-3-amino-3-deoxy-? -D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3 ,6-trideoxy-?-D-ribo-hexopyranosyl-(1.fwdarw. 4)]-2-deoxy-
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4))-2-deoxy-
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(16)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(14))-2-deoxy-
- Nebramycin factor 6; 3 inverted exclamation marka-Deoxykanamycin B; D-Streptamine, O-3-amino-3-deoxy-|A-D-glucopyranosyl-(1 inverted exclamation marku6)-O-[2,6-diamino-2,3,6-trideoxy-|A-D-ribo-hexopyranosyl-(1 inverted exclamation marku4)]-2-deoxy-; (2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol
- O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-D-streptamine
- O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1?6)]-O-[2,6-diamino-2,3 ,6-trideoxy-alpha-D-ribohexopyranosyl-(1?4)]-2-deoxy-D-streptamine
- O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(2,6-DIAMINO-2,3,6-TRIDEOXY-.ALPHA.-D-RIBO-HEXOPYRANOSYL-(1.ALPHA.6))-2-DEOXY-L-STREPTAMINE
- O-3-Amino-3-deoxy-?-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-?-D-ribohexopyranosyl-(1-4)]-2-deoxy-D-streptamine
- O-3-Amino-3-deoxy-|A-D-glucopyranosyl-(1 inverted exclamation marku6)-O-[2,6-diamino-2,3,6-trideoxy-|A-D-ribo-hexopyranosyl-(1 inverted exclamation marku4)]-2-deoxy-D-streptamine
- O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-a -D-ribo-hexopyranosyl-(1-4)]-2-deoxy-D-streptamine Deuterated; Nebramycin 6- Deuterated; Nebramycin VI- Deuterated; Tobramax-Deuterated; Tobramaxin- Deuterated; Tobrex-Deuterated;
- O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->6))-2-deoxy-L-streptamine
- Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.4)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1.fwdarw.6)]-2-deoxy-, D-
- Tobramycin; 4-O-(3-Amino-3-deoxy-a-d-glucopyranosyl)-2-deoxy-6-O-(2,6-diamino-2,3,6-trideoxy-a-d-ribo-hexopyranosyl)-l-streptamine; O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-D-Streptamine; 3'-Deoxykanamycin B; Deoxykanamycin B; NF 6; NSC 180514; Nebramycin 6; Nebramycin VI; Nebramycin factor 6; Tobracin; Tobradistin; Tobralex; Tobramax; Tobramaxin; Tobramicin; Tobramycetin; Tobramycin; Tobrex; Tobrin